Acer Therapeutics Inc (NASDAQ:ACER)

0.8999
Delayed Data
As of Jun 02
 +0.035 / +4.05%
Today’s Change
0.65
Today|||52-Week Range
4.56
-64.15%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Acer Therapeutics Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +1,122.36% increase from the last price of 0.90.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Acer Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.25
Sales
$550.0K
Reporting Date
Aug 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 67.53%
 
 
 
 
 
 
Growthannually 59.04%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.